Brought to you by:
Powered by wagescape.com
Labor Market Pulse
Abilene, TX Metro Edition
Focus: LIFE SCI
Abilene unemployment rises, but scientific talent pay doesn't cool.
4.2%
Abilene unemployment rate
Up from 3.7% in August; highest 2026 reading
$96,557
CRA advertised pay, metro
vs $90,956 national median, both up significantly
6.7% YoY
Education/health job growth, metro
Fastest-growing sector in Abilene MSA
56.2%
Texas pharma employer growth since 2019
415 establishments, $123,068 avg wage statewide
This Month's Takeaways
Clinical Research Associate pay is outrunning the national trend.
Metro CRA advertised pay sits at $96,557 against a national median of $90,956, both rising significantly — an unusual local premium for a market without major clinical trial infrastructure. Employers competing for CRA talent locally may be bidding against remote or hybrid postings tied to larger Texas biopharma hubs.
Lab Technician wages are flat while national rates soften.
Metro Lab Technician pay held stable at $45,314 even as the national median fell moderately to $47,402, narrowing the gap between Abilene and the broader market. Flat local demand suggests technician-level roles are not yet feeling the talent tightness affecting more credentialed positions.
Rising metro unemployment hasn't loosened specialized talent supply.
Abilene's jobless rate rose to 4.2% in September, up from 3.7% in August, yet Research Scientist advertised pay still climbed significantly — a sign that broader labor slack isn't reaching scientific and regulatory talent pools. Headcount planning should assume credential-driven roles remain tight even as general unemployment ticks upward.
Texas manufacturing buildout is reshaping outsourcing math statewide.
Lilly's and Bristol Myers Squibb's combined $8.8B in new Houston-area manufacturing capacity is pulling operators and quality specialists toward major metros, which may tighten the broader Texas labor pool Abilene employers draw from for CMC and manufacturing talent. Build-vs-outsource decisions for manufacturing-adjacent roles should account for rising competition from in-state megaprojects, not just national CDMO capacity.
Local Labor Conditions
Abilene's unemployment rate climbed to 4.2% in September, the highest reading of 2026, even as Dyess Air Force Base and Hendrick Health continue to anchor local employment and education/health services payrolls grow 6.7% year-over-year — the fastest of any sector in the metro. Statewide biomanufacturing investment (Eli Lilly's $6.5B Houston project, Bristol Myers Squibb's $2.3B facility) and tight national GLP-1 and CMC talent pools are pulling against a metro where life sciences employment remains concentrated in health systems and academic research rather than manufacturing or commercial biopharma.
Leadership & Talent Implications
Abilene's thin life sciences employer base means local compensation benchmarking should lean on Texas and national reference points — Dallas-area pay sits below U.S. average, but Research Scientist and Clinical Research Associate rates here are both moving up sharply, suggesting employers are already paying a premium to attract or retain scarce credentialed talent despite a metro with no major pharma or device manufacturing presence. Build-vs-outsource calculus for clinical operations and specialized CMC functions likely favors continued reliance on CROs/CDMOs given the absence of local manufacturing infrastructure, while quality and regulatory hiring may require broadening searches beyond the MSA. Consider reviewing whether current offers for Research Scientist and CRA roles reflect the national upward trend rather than static local history.
